One of the reasons for this occurrence is that the solid tumor-associated microenvironment often becomes hypoxic and induces TGF-β, which promotes the downregulation of activated NK cell receptors in patients with cancer; consequently, their killing activity that targets tumors is impaired (38). The gene discussed is TGFB1; the disease is cancer.